- 全部删除
 
您的购物车当前为空
DSS30 是一种 P25/CDK5抑制剂。DSS30通过抑制淀粉样前体蛋白裂解酶1 (BACEl) 磷酸化,减少 β-淀粉样蛋白 (Aβ) 的分泌发挥作用。DSS30 可用于预防和治疗阿尔茨海默病等神经退行性疾病。


为众多的药物研发团队赋能,
让新药发现更简单!
DSS30 是一种 P25/CDK5抑制剂。DSS30通过抑制淀粉样前体蛋白裂解酶1 (BACEl) 磷酸化,减少 β-淀粉样蛋白 (Aβ) 的分泌发挥作用。DSS30 可用于预防和治疗阿尔茨海默病等神经退行性疾病。
| 规格 | 价格 | 库存 | 数量 | 
|---|---|---|---|
| 1 mg | ¥ 2,350  | In stock | |
| 5 mg | ¥ 5,630  | In stock | |
| 10 mg | ¥ 7,790  | In stock | |
| 25 mg | ¥ 11,200  | In stock | |
| 50 mg | ¥ 13,800  | In stock | |
| 100 mg | ¥ 17,500  | In stock | |
| 500 mg | ¥ 34,800  | In stock | 
DSS30 相关产品
| 产品描述 | DSS30 is a P25/CDK5 inhibitor.DSS30 acts by inhibiting the phosphorylation of amyloid precursor protein cleaving enzyme 1 (BACEl), which reduces the secretion of β-amyloid (Aβ).DSS30 can be used for the prevention and treatment of neurodegenerative diseases such as Alzheimer's disease.  | 
| 体外活性 | DSS30 (50 μM, 2 h) demonstrates a maximum 50% inhibition in the P25/CDK5 complex activity, along with a reduction in the phosphorylation levels of BACE1 or Tau.[1]  | 
| 分子量 | 367.87 | 
| 分子式 | C16H14ClNO3S2 | 
| CAS No. | 883027-32-5 | 
| Smiles | CC=1C=2C(SC1S(NC3=C(OC)C=CC=C3)(=O)=O)=CC=C(Cl)C2 | 
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||
| 溶解度信息 | DMSO: 10 mg/mL (27.18 mM), Sonication is recommended.   | |||||||||||||||||||||||||
溶液配制表  | ||||||||||||||||||||||||||
DMSO 
  | ||||||||||||||||||||||||||
评论内容